Filing a DMF for L-Leucine (U-13C6) with the U.S. FDA
Filing a drug master file (DMF) for L-Leucine (U-13C6) can be a useful mechanism to market your
L-Leucine (U-13C6) to the U.S. Drug Industry. Typical L-Leucine (U-13C6) producers who have filed a DMF for
L-Leucine (U-13C6) include:
-
Cambridge Isotope Laboratories Inc
Registrar Corp can help you to properly prepare and submit your L-Leucine (U-13C6) DMF to FDA.
As your Agent, Registrar Corp will perform the following administrative functions:
-
Format, assemble and deliver your L-Leucine (U-13C6) DMF to FDA
-
Submit letters of authorization regarding your L-Leucine (U-13C6) to FDA
-
Provide changes, additions and maintenance of your L-Leucine (U-13C6) DMF
-
Respond to issues relating to ownership of your L-Leucine (U-13C6) DMF
-
Assist with submission of responses to FDA concerning your L-Leucine (U-13C6) DMF
-
Perform any required annual updates for your L-Leucine (U-13C6) DMF
For more information about filing a DMF for L-Leucine (U-13C6), simply click below:
U.S. FDA Regulations:
U.S. FDA DMF Regulation: 21 C.F.R. Section 314.420
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
